Printer Friendly

Mylan gets temporary restraining order against GSK, Apotex prohibiting supply, sale, importing of generic Paxil CR.

M2 PHARMA-September 22, 2010-Mylan gets temporary restraining order against GSK, Apotex prohibiting supply, sale, importing of generic Paxil CR(C)2010 M2 COMMUNICATIONS

22 September 2010 - US Mylan Inc (NASDAQ: MYL) said yesterday it has received a temporary restraining order from the US District Court for the District of New Jersey that prohibits Apotex from selling and/or importing all three strengths of a generic version of GlaxoSmithKline's (LON: GSK) Paxil CR, Paroxetine Hydrochloride (HCl) Extended-release (ER) Tablets, 12.5 mg, 25 mg and 37.5 mg.

The order also prohibits GlaxoSmithKline from supplying Apotex with a generic version of the product.

The order was entered yesterday, and the court has scheduled further hearings on the matter for 18 October. Mylan further said it is currently selling all three strengths of Paroxetine HCl ER.

((Comments on this story may be sent to info@m2.com))

COPYRIGHT 2010 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2010 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:M2 Pharma
Date:Sep 22, 2010
Words:145
Previous Article:Sanofi-aventis to launch blood glucose monitoring devices BGStar, iBGStar.
Next Article:Aeras' and Crucell's TB vaccine candidate commences Phase II testing in infants.
Topics:

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters